Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction
ComConEndo
1 other identifier
interventional
62
1 country
1
Brief Summary
Does comforting conversation during colonoscopy improve on patient satisfaction, compliance and pain management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Sep 2015
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2015
CompletedFirst Posted
Study publicly available on registry
June 29, 2015
CompletedStudy Start
First participant enrolled
September 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedSeptember 29, 2015
September 1, 2015
4 months
June 23, 2015
September 28, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Patient Satisfaction
Questionnaire with 5 point Likert like scale
on average 20 minutes after completed colonoscopy.
Secondary Outcomes (1)
Per-procedural Pain management
From inclusion to completed procedure. On average 45 minutes from first to last measurement.
Study Arms (2)
Comforting Conversation
EXPERIMENTALConversation according to the initital qualitative study.
Standard Communication
ACTIVE COMPARATORStandard information prior to and during endoscopy.
Interventions
Pain management, distraction, diversion, empathy. Dependent on qualitative study results.
Information on procedure type, duration, findings, key landmarks, possibility of analgesic treatment, pause in procedure.
Eligibility Criteria
You may qualify if:
- Age 18-85
- Colonoscopy
- Written informed content
You may not qualify if:
- ASA Class 4 or higher
- BMI 40 or higher
- Analgesics taken prior to procedure
- Pregnancy or breast feeding
- Allergy to Fentanyl/Midazolam
- Daily consumption of opioids
- Unable to complete questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Endoscopy, Gastrounit, Herlev Hospital
Herlev, Region H, 2730, Denmark
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
June 23, 2015
First Posted
June 29, 2015
Study Start
September 1, 2015
Primary Completion
January 1, 2016
Study Completion
January 1, 2016
Last Updated
September 29, 2015
Record last verified: 2015-09